The isotype composition and avidity of naturally acquired anti- Plasmodium falciparum antibodies: Differential patterns in clinically immune Africans and Amazonian patients

American Journal of Tropical Medicine and Hygiene

Volumn 55, Issue 3, 1996, Pages 315-323

  Ferreira, Marcelo Urbano ^a   Kimura, Emilia Akemi Shiraishi ^a   De Souza, Jose Maria ^b   Katzin, Alejandro Miguel ^a  

^a UNIVERSITY OF SÃO PAULO   (Brazil)

^b INSTITUTO EVANDRO CHAGAS   (Brazil)

Author keywords

[No Author keywords available]

Indexed keywords

IMMUNOGLOBULIN A ANTIBODY; IMMUNOGLOBULIN G ANTIBODY; IMMUNOGLOBULIN M ANTIBODY;

ADULT; AFRICA; AGED; ANTIBODY PRODUCTION; ANTIBODY RESPONSE; ANTIBODY TITER; ARTICLE; BRAZIL; HOST RESISTANCE; HUMAN; IMMUNOGLOBULIN BLOOD LEVEL; INFECTION RESISTANCE; MAJOR CLINICAL STUDY; MALARIA; MALE; PLASMODIUM FALCIPARUM;

PLASMODIUM FALCIPARUM;

EID: 0029784666     PISSN: 00029637     EISSN: None     Source Type: Journal    
DOI: 10.4269/ajtmh.1996.55.315     Document Type: Article

References (53)

1. Marsh K, 1994. Immunology of human malaria. Gilles HM, Warrell DA, eds. Bruce-Chwatl's Essential Malariology. London: Edward Arnold, 60-77.
2. Marques AC, 1995. Dados epidemiologicos da malaria em todo o Brasil referentes a 1993. Rev Soc Bras Med Trop 28: 141-155.
3. Marques AC, 1987. Human migration and the spread of malaria in Brazil. Parasitol Today 3: 166-170.
4. Prata A, Urdaneta M, McGreevy PB, Tada MS, 1988. Infrequency of asymptomatic malaria in an endemic area in Amazonas, Brazil. Rev Soc Bras Med Trop 23: 51-54.
5. Singer B, Sawyer DO, 1992. Perceived malaria illness reports in mobile populations. Health Policy Planning 7: 40-45.
6. Andrade ALSS, Martelli CMT, Oliveira RM, Arias JR, Zicker F, Pang L, 1995. High prevalence of asymptomatic malaria in gold mining areas in Brazil. Clin Infect Dis 20: 475.
7. Jefferis R, Kumararatne DS, 1990. Selective IgG subclass deficiency: quantification and clinical relevance. Clin Exp Immunol 87: 357-367.
8. Bouharoun-Tayoun H, Attanath P. Sabchareon A, Chongsupha-jarsiddhi T, Druilhe P, 1990. Antibodies that protect humans against Plasmodium falciparum blood stages do not on their own inhibit parasite growth in vitro but act in cooperation with monocytes. J Exp Med 172: 1633-1641.
9. Gysin J. Druilhe P, Pereira da Silva, L, 1992. Mechanisms of immune protection in the asexual blood stage infection by Plasmodium falciparum: analysis by in vitro and ex-vivo assays. Mem Inst Oswaldo Cruz 87 (suppl V): 145-149.
10. White WI, Evans CB, Taylor DW, 1991. Anti-malarial antibodies of the immunoglobulin G2a isotype modulate parasitemias in mice infected with Plasmodium yoelii. Infect Immun 59: 3547-3556.
11. Sabchareon A, Burnouf T, Ouattara D, Attanath P Bouharoun-Tayoun H, Chantavanich P, Foucault C, Chongsuphajaisiddhi T, Druilhe P, 1991. Parasitological and clinical human response to immunoglobulin administration in falciparum malaria. Am J Trop Med Hyg 45: 297-308.
12. Erunkulu OA, Hill AVS, Kwiatkowski DP, Todd JE, Iqbal J, Berzins K, Riley EM, Greenwood BM, 1992. Severe malaria in Gambian children is not due to lack of previous exposure to malaria. Clin Exp Immunol 89: 296-300.
13. Bouharoun-Tayoun H, Druilhe P, 1992. Antibodies in falciparum malaria: what matters most, quantity or quality? Mem Inst Oswaldo Cruz 87 (suppl III): 229-234.
14. Groux H, Gysin J, 1990. Opsonization as an effector mechanism in human protection against asexual blood stages of Plasmodium falciparum: functional role of IgG subclasses. Res Immunol 141: 529-542.
15. Bouharoun-Tayoun H, Druilhe P, 1992. Plasmodium falciparum malaria: evidence for an isotype imbalance which may be responsible for delayed acquisition of protective immunity. Infect Immun 60: 1473-1481.
16. Steward MIN, Lew AM, 1985. The importance of antibody affinity in the performance of immunoassays for antibody. J Immunol Methods 78: 173-190.
17. Camargo LMA, Ferreira MU, Krieger H, Camargo EP, Pereira da Suva LH, 1994. Unstable hypoendemic malaria in Rondonia (Western Amazon Region, Brazil): epidemic outbreaks and work-associated incidence in an agro-industrial rural settlement. Am J Trop Med Hyg 51: 16-25.
18. Ferreira MU, Camargo LMA, Ferreira CS, 1994. The median age of primary malaria infection in an Amazonian community: probit analysis of cross-sectional data. Acta Trop 58: 73-78.
19. Ferreira MU, Kimura ES, Camargo LMA, Alexandre COP, Pereira da Silva LH, Katzin AM, 1994. Antibody response against Plasmodium falciparum exoantigens and somatic antigens: a longitudinal survey in a rural community in Rondonia, Western Brazilian Amazon. Acta Trop 57: 35-46.
20. Behr C, Sarthou J-L, Rogier C, Trape J-F, Dat MHQ, Michel JC, Aribot G, Dieye A, Claverie J-M, Druilhe P, Dubois P, 1992. Antibodies and reactive T cells against the malaria heat-shock protein Pf72/Hsp 70-1 and derived peptides in individuals continuously exposed to Plasmodium falciparum. J Immunol 149: 3321-3330.
21. Konate L, Diagne N, Brahimi K, Faye O, Legros F, Rogier C, Petrarca V, Trape J-F 1994. Biologie des vecteurs et transmission de Plasmodium falciparum, P, malariae et P ovale dans un village de savane d'Afrique de l'Ouest (Dielmo, Senegal). Parasite I: 325-333.
22. Trape J-F, Rogier C, Konate L, Diagne N, Bouganali H, Canque B, Legros F, Badji A, Ndiaye G, Ndiaye P, Brahimi K, Faye O, Druilhe P, Pereira da Silva L, 1994. The Dielmo project: a longitudinal study of natural malaria infection and the mechanisms of protective immunity in a community living in a holoendemic area of Senegal. Am J Trop Med Hyg 51: 123-137.
23. Sawyer D, 1993. Economic and social consequences of malaria in new colonization projects in Brazil. Soc Sei Med 37: 11311136.
24. Arruda M, Carvalho MB, Nussenzweig RS, Maracic M, Ferreira AW, Cochrane AH, 1986. Potential vectors of malaria and their different susceptibility to Plasmodium falciparum and Plasmodium vivax in northern Brazil identified by immunoassay. Am J Trop Med Hyg 35: 873-881.
25. Souza JM, 1983. A phase II clinical trial of mefloquine in Brazilian male subjects. Bull World Health Organ 67: 815-820.
26. Carvalho ME, Ferreira MU, Souza MRD, Ninomia RT, Matos GF, Camargo LMA, Ferreira CS, 1992. Malaria seroepidemiology: comparison between indirect fluorescent antibody test and enzyme immunoassay using bloodspot eluates. Mem Inst Oswaldo Cruz 87: 205-208.
27. Katzin AM, Kimura ES, Alexandre COP, Ramos AMSV, 1991. Detection of antigens in urine of patients with acute falciparum and vivax malaria infections. Am J Trop Med Hyg 45: 453-462.
28. Trager W, Jensen JB, 1976. Human malaria parasites in continuous culture. Science 193: 673-675.
29. Pasvol G, Wilson RJM, Smalley ME, Brown J, 1978. Separation of viable schizont-infected red cells of Plasmodium falciparum from human blood. Ann Trop Med Parasitol 72: 87-88.
30. Demedts P, Vermeulen-van Overmeir C, Wery M, 1987. Simultaneous use of Plasmodium falciparum antigen and red blood cell control antigen in the enzyme-linked immunosorbent assay for malaria. Am J Trop Med Hyg 36: 257-263.
31. Jefferis R, Reimer CB, Skvaril F, de Lange G, Ling NR, Löwe J, Walker MR, Phillips DJ, Alorsio CH, Wells TW, Vaerman JP, Magnusson CG, Kubagawa H, Cooper M, Vertdal F, Vandvrk B, Haaijman JJ, Makela O, Sarnesto A, Lando Z, Gergely J, Rajnavolgyi E, Laslo G, Radl J, Molinaro GA, 1985. Evaluation of monoclonal antibodies having specificity for human IgG sub-classes: results of an IUIS/WHO collaborative study. Immunol Lett 10: 223-252.
32. Wahlgren M, Berzins K, Perlman P, Persson M, 1983. Characterization of the humoral immune response in Plasmodium falciparum malaria. II. IgG subclass levels of anti-P. falciparum antibodies in different sera. Clin Exp Immunol 54: 135142.
33. Platt JH, Shore AB, Smithyman AM, Kampfer GL, 1981. A computerized ELIS A system for the determination of total and antigen-specific immunoglobulins in serum and secretions. J Immunoassay 2: 59-74.
34. Poole L, Borchers M, Burke PM, 1982. Some Common BASIC Programs: IBM Personal Computer Edition. New York: McGraw-Hill.
35. Fomsgaard A, Dinesen B, 1987. ELISA for human IgG and IgM anti-lipopolysaccharide antibodies with indirect standardization. J Immunoassay 8: 333-350.
36. Woodward MP, Young, WW Jr, Bloodgood RA, 1985. Detection of monoclonal antibodies specific for carbohydrate epitopes using periodate oxidation. J Immunol Methods 78: 143153.
37. Pullen GR, Fitzgerald MG, Hosking CS, 1986. Antibody avidity determination by ELISA using thiocyanate elution. J Immunol Methods 86: 83-87.
38. Macdonald RA, Hosking CS, Jones CL, 1988. The measurement of relative antibody affinity by ELISA using thiocyanate elution. J Immunol Methods 131: 277-282.
39. Potter M, Smith-Gill SJ, 1990. Physiology of immunoglobulins. Oppenheim JJ, Shevach EM, eds. Immunophysiology. New York: Oxford University Press, 129-151.
40. Thelu J, Sheick-Zakiuddin I, Boudin C, Peyron F, Picot S, Ambroise-Thomas P, 1991. Development of natural immunity in Plasmodium falciparum: study of antibody response by Western immunoblotting. J Clin Microbiol 29: 510-518.
41. Wahlgren M, Perlmann H, Berzins K, Bjorkman A, Larsson A, Ljungstrom I, Patarroyo ME, Perlmann P, 1986. Charactenzation of the humoral immune response in Plasmodium falciparum malaria. III. Factors influencing the coexpression of antibody isotypes (IgM and IgG-1 to 4). Clin Exp Immunol 63: 343-353.
42. Howard RJ, Pasloske BL, 1993. Target antigens for asexual malaria vaccine development. Parasitol Today 9: 369-372.
43. Gysin J, Gavoille S, Mattei D, Scherf A, Bonnefoy S, Mercereau-Puijalon O, Feldmann T, Muller-Hill B, Pereira da Suva L, 1993. In vitro phagocytosis inhibition assay for the screening of potential candidate antigens for sub-unit vaccines against the asexual blood stage of Plasmodium falciparum. J Immunol Methods 159: 209-219.
44. van Ree R, Aalberse RC, 1995. Demonstration of carbohydratespecific immunoglobulin G4 antibodies in sera of patients receiving grass pollen immunotherapy. Int Arch Allergy Immunol 106: 146-148.
45. Devey ME, Steward MW, 1988. The role of antibody affinity in the performance of solid phase assays. Kemeny DM, Challacombe SJ, ed. ELISA and Other Solid Phase Immunoassays. Theoretical and Practical Aspects. Chichester: United Kingdom: John Wiley & Sons, 135-153.
46. Inouye S, Hasegawa A, Matsuno S, Katow S, 1984. Changes in antibody avidity after virus infections: detection by an immunosorbent assay in which a mild protein-denaturating agent is employed. J Clin Microbiot 20: 525-529.
47. Roost H-R Bachmann MF, Haag A, Kalinke U, Pliska V, Hengartner H, Zinkemagel RM, 1995. Early high-affinity neutralizing anti-viral IgG responses without further overall improvements of affinity. Proc Nail Acad Sei USA 92: 1257-1261.
48. Banic DM, Vianna-Martins FS, Souza JM, Peixoto TC, DanielRibeiro CT, 1991. Polyclonal B-lymphocyte stimulation in human malaria and its association with ongoing parasitemia. Am J Trop Med Hyg 44: 571-577.
49. Targett GAT, 1992. Spf66, a candidate synthetic malaria vaccine: immunogenicity versus protection. Parasitol Today 8: 354-355.
50. Briere F, Servet-Delprat C, Bridon J-M, Saint-Remy J-M, Banchereau J, 1994. Human interleukin 10 induces naive surface immunoglobulin D+ (slgD+) B cells to secrete IgGl and IgG3. J Exp Med 179: 757-762.
51. Kenney JS, Hughes BJN, Masada M,P Allison AC, 1989. Influence of adjuvants on the quantity, affinity, isotype and epitope specificity of murine antibodies. J Imtnunol Methods 121: 157-166.
52. ten Hagen TLM, Sulzer AJ, Kidd MR, Lal AA, Hunter RL, 1993. Role of adjuvants in the modulation of antibody isotype, specificity and induction of protection by whole bloodstage Plasmodium yoelii vaccines. J Immunol 151: 7077-7085.
53. Hunter RL, Kidd MR, Olsen MR, Patterson PS, Lal AA, 1995. Induction of long-lasting immunity to Plasmodium yoelii malaria with whole blood-stage antigens and copolymer adjuvants. J Immunol 154: 1762-1769.